The effectiveness of IgM and IgG antibodies detection in the diagnosis of COVID-19 has been investigated previously, and it was shown in serology-based tests that sensitivity increased as the time from symptom onset increased, and sensitivity was relatively lower before seven days.20 This evidence concerns the gene CD40LG and COVID-19.